Suren Ajjarapu (TRxADE Health)

The next SPAC is here, com­ing from a phar­ma e-com­merce CEO, as a Flori­da biotech prices at the low end

The newest health­care blank-check com­pa­ny has ar­rived, com­ing from the CEO of a com­pa­ny that is at­tempt­ing to shake up the dig­i­tal phar­ma­ceu­ti­cal space.

The SPAC known as Aes­ther Health­care Ac­qui­si­tion filed for its ini­tial of­fer­ing late Mon­day, putting down $100 mil­lion as its raise es­ti­mate. Led by Suren Aj­jara­pu, chief ex­ec­u­tive of on­line drug mar­ket­place TRx­ADE Health, the SPAC is tar­get­ing phar­ma­ceu­ti­cals, medtech and health­care IT.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.